Ikena Oncology, Inc. financial data

Symbol
IKNA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
50 Northern Ave., Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.26K % +65.3%
Debt-to-equity 13 % -27.9%
Return On Equity -44 % -2.3%
Return On Assets -37.3 % -2.36%
Operating Margin -823 % -81.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.3M shares +33.1%
Common Stock, Shares, Outstanding 48.3M shares +33.1%
Entity Public Float 179M USD
Common Stock, Value, Issued 48K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 48.3M shares +33.1%
Weighted Average Number of Shares Outstanding, Diluted 48.3M shares +33.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.16M USD -41.4%
Research and Development Expense 53.7M USD -18%
General and Administrative Expense 25.6M USD +19.4%
Operating Income (Loss) -78.1M USD -12.5%
Nonoperating Income (Expense) 2.11M USD +62.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.1M USD -13.4%
Income Tax Expense (Benefit) 27K USD
Net Income (Loss) Attributable to Parent -70.1M USD -5.97%
Earnings Per Share, Basic -1.57 USD/shares +13.7%
Earnings Per Share, Diluted -1.57 USD/shares +13.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 52.9M USD +80.2%
Marketable Securities, Current 104M USD -3.68%
Cash, Cash Equivalents, and Short-term Investments 176M USD +11.9%
Other Assets, Current 1.15M USD +19.3%
Assets, Current 161M USD +14.2%
Property, Plant and Equipment, Net 864K USD -72.4%
Operating Lease, Right-of-Use Asset 5.24M USD +6.57%
Assets 173M USD +13.4%
Accounts Payable, Current 1.91M USD -30.8%
Employee-related Liabilities, Current 1.59M USD +40.9%
Contract with Customer, Liability, Current 659K USD -94.6%
Liabilities, Current 10.2M USD -27.1%
Contract with Customer, Liability, Noncurrent 2.5M USD -88.8%
Operating Lease, Liability, Noncurrent 6.3M USD +83.8%
Other Liabilities, Noncurrent 964K USD
Liabilities 17.4M USD +0.32%
Accumulated Other Comprehensive Income (Loss), Net of Tax -313K USD +36.3%
Retained Earnings (Accumulated Deficit) -299M USD -30.7%
Stockholders' Equity Attributable to Parent 155M USD +15.1%
Liabilities and Equity 173M USD +13.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.3M USD +7.48%
Net Cash Provided by (Used in) Financing Activities 76M USD +6839%
Net Cash Provided by (Used in) Investing Activities -48.7M USD -351%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 48.3M shares +33.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 54.1M USD +79.2%
Deferred Tax Assets, Valuation Allowance 101M USD +68.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 103M USD +66.1%
Operating Lease, Liability 10.7M USD +88.6%
Depreciation 219K USD -5.2%
Payments to Acquire Property, Plant, and Equipment 414K USD -71.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -69.9M USD -5.68%
Lessee, Operating Lease, Liability, to be Paid 12M USD +86%
Property, Plant and Equipment, Gross 5.07M USD +0.84%
Operating Lease, Liability, Current 3.44M USD +79.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.21M USD +124%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.92M USD +115%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.29M USD +67.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.17M USD +63.6%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) -169K USD -726%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 949K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 719K USD -12%
Operating Lease, Payments 2.53M USD +42.8%
Additional Paid in Capital 454M USD +24.8%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 68K USD +152%
Current Federal Tax Expense (Benefit) -237K USD
Share-based Payment Arrangement, Expense 7.63M USD +0.11%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%